Novartis Appoints Mukul Mehta as New CFO, Harry Kirsch Retires
Ticker: NVSEF · Form: 6-K · Filed: Jul 17, 2025 · CIK: 1114448
| Field | Detail |
|---|---|
| Company | Novartis Ag (NVSEF) |
| Form Type | 6-K |
| Filed Date | Jul 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, management-transition, cfo-appointment
Related Tickers: NVS
TL;DR
Novartis names Mukul Mehta as new CFO starting March 2026, replacing Harry Kirsch after 22 years.
AI Summary
Novartis AG announced on July 17, 2025, that Mukul Mehta will become the new Chief Financial Officer (CFO) effective March 16, 2026. Mehta, currently Head of Business Planning and Analysis, Digital Finance, and Tax, will join the Executive Committee. This appointment follows the retirement of Harry Kirsch, who served Novartis for 22 years.
Why It Matters
A CFO transition can signal shifts in financial strategy and leadership, impacting investor confidence and the company's financial direction.
Risk Assessment
Risk Level: low — This is a routine executive leadership change announcement with no immediate financial implications.
Key Players & Entities
- Novartis AG (company) — Filer of the report and subject of the announcement
- Mukul Mehta (person) — Appointed Chief Financial Officer
- Harry Kirsch (person) — Retiring Chief Financial Officer
- March 16, 2026 (date) — Effective date of Mukul Mehta's appointment
- July 17, 2025 (date) — Date of the report
FAQ
Who is replacing Harry Kirsch as CFO of Novartis?
Mukul Mehta has been appointed as the new Chief Financial Officer, effective March 16, 2026.
When will Mukul Mehta's appointment as CFO be effective?
Mukul Mehta's appointment as Chief Financial Officer will be effective March 16, 2026.
How long did Harry Kirsch work at Novartis?
Harry Kirsch had an extraordinary 22-year career at Novartis.
What is Mukul Mehta's current role at Novartis?
Mukul Mehta is currently the Head of Business Planning and Analysis (BPA), Digital Finance and Tax.
Will Mukul Mehta join the Executive Committee?
Yes, Mukul Mehta will join the Executive Committee (ECN) upon his appointment as CFO.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 17, 2025 by Mukul Mehta regarding NOVARTIS AG (NVSEF).